ARCHIVES

CMS Issues Coverage Decision For Provenge in Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Move To NCI director’s Office gives Greater Visibility To NCI Liaison Office

September 13, 1996

FDA Continues Bureaucratic Delays Of Cancer INDs

January 30, 1976

Paul Marks To Chair Search Committee For NCI Director

January 20, 1995

In Brief: NCI Construction Authority To Continue Under Pane’s Plan: NCAB hearing In Philadelphia

March 11, 1988

Vasopermeation Technology Awarded Patent For CA Firm.

September 28, 2001

ODAC Member Critical Of Amgen For Price Incentives.

March 21, 2008